Drug Resistance Updates

853 papers and 60.0k indexed citations i.

About

The 853 papers published in Drug Resistance Updates in the last decades have received a total of 60.0k indexed citations. Papers published in Drug Resistance Updates usually cover Molecular Biology (438 papers), Oncology (307 papers) and Cancer Research (137 papers) specifically the topics of Antibiotic Resistance in Bacteria (99 papers), Drug Transport and Resistance Mechanisms (86 papers) and Cancer therapeutics and mechanisms (55 papers). The most active scholars publishing in Drug Resistance Updates are Yehuda G. Assaraf, Dennis Carney, Hélène Pelicano, Peng Huang, Zhe‐Sheng Chen, Marcelo E. Tolmasky, María Soledad Ramírez, Ola Sköld, David S. Perlin and Viktor Brabec.

In The Last Decade

Fields of papers published in Drug Resistance Updates

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Drug Resistance Updates. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Drug Resistance Updates

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Drug Resistance Updates. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Drug Resistance Updates with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025